Rpg Investment Advisory, LLC Gilead Sciences, Inc. Transaction History

Rpg Investment Advisory, LLC

$700 Million
Q3 2024

A detailed history of Rpg Investment Advisory, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Rpg Investment Advisory, LLC holds 83,878 shares of GILD stock, worth $7.66 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares

83,878

Previous 99,965 16.09%

Holding current value

$7.66 Million

Previous $6.86 Million 2.51%

% of portfolio

1.0%

Previous 1.01%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$66.59 - $83.99 $1.07 Million - $1.35 Million	-16,087 Reduced 16.09%	83,878 $7.03 Million
Q2 2024 Aug 07, 2024	BUY	$63.15 - $72.88 $1.49 Million - $1.72 Million	23,665 Added 31.02%	99,965 $6.86 Million
Q1 2024 May 07, 2024	BUY	$71.58 - $87.29 $350,026 - $426,848	4,890 Added 6.85%	76,300 $5.59 Million
Q4 2023 Jan 29, 2024	BUY	$73.27 - $83.09 $121,554 - $137,846	1,659 Added 2.38%	71,410 $5.78 Million
Q3 2023 Nov 08, 2023	BUY	$73.94 - $80.67 $104,181 - $113,664	1,409 Added 2.06%	69,751 $5.23 Million
Q2 2023 Aug 10, 2023	SELL	$76.01 - $86.7 $94,404 - $107,681	-1,242 Reduced 1.78%	68,342 $5.27 Million
Q1 2023 May 08, 2023	SELL	$77.31 - $88.08 $2.38 Million - $2.71 Million	-30,812 Reduced 30.69%	69,584 $5.77 Million
Q4 2022 Feb 06, 2023	SELL	$62.32 - $89.47 $2.63 Million - $3.78 Million	-42,268 Reduced 29.63%	100,396 $8.62 Million
Q3 2022 Nov 07, 2022	SELL	$59.54 - $68.01 $63,350 - $72,362	-1,064 Reduced 0.74%	142,664 $8.8 Million
Q2 2022 Jul 26, 2022	BUY	$57.72 - $65.01 $116,248 - $130,930	2,014 Added 1.42%	143,728 $8.88 Million
Q1 2022 May 10, 2022	BUY	$57.92 - $72.58 $53,923 - $67,571	931 Added 0.66%	141,714 $8.43 Million
Q4 2021 Jan 28, 2022	BUY	$64.88 - $73.64 $194,575 - $220,846	2,999 Added 2.18%	140,783 $10.2 Million
Q3 2021 Oct 25, 2021	SELL	$67.69 - $73.03 $52,662 - $56,817	-778 Reduced 0.56%	137,784 $9.62 Million
Q2 2021 Aug 03, 2021	BUY	$63.47 - $69.35 $738,917 - $807,372	11,642 Added 9.17%	138,562 $9.54 Million
Q1 2021 Apr 27, 2021	BUY	$60.0 - $68.46 $92,640 - $105,702	1,544 Added 1.23%	126,920 $8.2 Million
Q4 2020 Jan 27, 2021	BUY	$56.65 - $64.55 $665,977 - $758,849	11,756 Added 10.35%	125,376 $7.3 Million
Q3 2020 Nov 06, 2020	BUY	$62.1 - $78.08 $101,160 - $127,192	1,629 Added 1.45%	113,620 $7.18 Million
Q2 2020 Aug 04, 2020	SELL	$72.34 - $84.0 $18,808 - $21,840	-260 Reduced 0.23%	111,991 $8.62 Million
Q1 2020 Apr 21, 2020	SELL	$62.63 - $80.22 $84,550 - $108,297	-1,350 Reduced 1.19%	112,251 $8.39 Million
Q4 2019 Feb 07, 2020	BUY	$61.62 - $67.78 $116,338 - $127,968	1,888 Added 1.69%	113,601 $7.38 Million
Q3 2019 Oct 28, 2019	BUY	$62.51 - $69.0 $287,108 - $316,917	4,593 Added 4.29%	111,713 $7.08 Million
Q2 2019 Jul 10, 2019	BUY	$61.87 - $69.38 $291,160 - $326,502	4,706 Added 4.6%	107,120 $7.24 Million
Q1 2019 Apr 15, 2019	BUY	$62.53 - $70.05 $18,071 - $20,244	289 Added 0.28%	102,414 $6.66 Million
Q4 2018 Jan 15, 2019	BUY	$60.54 - $79.0 $6,719 - $8,769	111 Added 0.11%	102,125 $6.39 Million
Q3 2018 Nov 05, 2018	SELL	$71.28 - $78.92 $29,866 - $33,067	-419 Reduced 0.41%	102,014 $7.88 Million
Q2 2018 Nov 26, 2018	BUY	$64.88 - $75.68 $1.55 Million - $1.81 Million	23,855 Added 30.36%	102,433 $7.26 Million
Q2 2018 Aug 06, 2018	SELL	$64.88 - $75.68 $1.44 Million - $1.68 Million	-22,251 Reduced 22.07%	78,578 $5.6 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $33,943 - $41,380	-466 Reduced 0.46%	100,829 $7.6 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $110,567 - $129,790	1,554 Added 1.56%	101,295 $7.26 Million
Q3 2017 Feb 05, 2019	SELL	$72.11 - $85.47 $4,759 - $5,641	-66 Reduced 0.07%	99,741 $8.08 Million
Q2 2017 Feb 04, 2019	BUY	N/A	99,807	99,807 $7.06 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rpg Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rpg Investment Advisory, LLC with notifications on news.

Account

Rpg Investment Advisory, LLC Gilead Sciences, Inc. Transaction History